You are here: HomeSolutionsIndustriesConsumer Health
print my pages

Country Report

Consumer Health in India

Mar 2011

Price: $2,400

About this Report

About this Report

Delivery method: instant download
Report format: PDF doc_pdf.png (download a sample)
Market statistics: Excel workbook doc_excel_table.png (download a sample)

Overview

Discover the latest market trends and uncover sources of future market growth for the Consumer Health industry in India with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Consumer Health industry in India, our research will save you time and money while empowering you to make informed, profitable decisions.

When you purchase this report, you also get the data and the content from these category reports in India for free:

The Consumer Health in India market research report includes:

  • Analysis of key supply-side and demand trends
  • Detailed segmentation of international and local products
  • Historic volumes and values, company and brand market shares
  • Five year forecasts of market trends and market growth  
  • Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

  • What is the market size of Consumer Health in India?
  • What are the major brands in India?
  • What are the main trends in OTC Healthcare?

Why buy this report?

  • Gain competitive intelligence about market leaders
  • Track key industry trends, opportunities and threats
  • Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Sample Analysis

EXECUTIVE SUMMARY

Consumer Healthcare gains momentum

With manufacturers continually updating and improving on major brands, frequent weather changes and a flu epidemic raising consumer awareness regarding both curative and preventive consumer healthcare products, sales gained momentum towards the end of the review period. Demand for basic products increased in rural areas in line with education levels and expanding distribution networks. Moreover, rising consumer sophistication in urban areas created demand for lifestyle-related products such as weight-loss supplements and emergency contraceptives, as well as sophisticated formats for common ailments such as acidity and nasal congestion.

UTC sales remain rampant

OTC brands faced stiff competition from Rx-only brands in analgesics, cough and cold products and digestive remedies. Chemists/pharmacists openly sell restricted products to paying customers without checking the prescription in India. With consumers perceiving Rx-only brands as being more effective and faster acting, UTC sales remained rampant in 2010.With Rx-only brands being more expensive and thus offering more lucrative retail mark-ups to chemists, OTC marketers faced severe challenges in competing with Rx-only brands towards the end of the review period.

Direct sellers outpace store-based brands

Despite double-digit growth in the major store-based brands, including Dabur, Revital and Glucon D, direct-selling brands outpaced market growth in 2009 and 2010. Word-of-mouth marketing by trusted friends, educational seminars and workshops, and the opportunity to earn additional income, attracted a large number of new distributors and consumers for Amway, Herbalife and Forever Living towards the end of the review period.

Independent Chemists Remain Dominant

While chained chemists/pharmacists continued to see robust outlet expansion in India in 2010, the retailing landscape for consumer healthcare products continued to be overwhelmingly dominated by independent chemist outlets. Supermarkets expanded shelf space for consumer healthcare products, particularly with the launch of several attractive new products in sports nutrition, weight management and supplements.

Robust growth to continue despite regulatory uncertainty

While regulatory uncertainty regarding labelling and retailing of products is expected to remain a hindrance to the expansion of multinationals and new entrants, robust growth is predicted for consumer healthcare in India in coming years. Players are expected to boost growth in mature categories such as decongestants and antacids by promoting newly launched formats. Emerging categories such as emergency contraception and meal replacement slimming products will be boosted by changing urban lifestyles.

Table of Contents

Table of Contents

Consumer Health in India - Industry Overview

EXECUTIVE SUMMARY

Consumer Healthcare gains momentum

UTC sales remain rampant

Direct sellers outpace store-based brands

Independent Chemists Remain Dominant

Robust growth to continue despite regulatory uncertainty

KEY TRENDS AND DEVELOPMENTS

UTC Sales Remain Rampant

Small SKUs haveMajorImpact

Modernisation of AyurvedicProducts

Direct Sellers Outpace Other Companies

New Regulations for Supplements Expected

TERRITORY KEY TRENDS AND DEVELOPMENTS

East and North-east India

North India

South India

West India

RURAL VS URBAN KEY TRENDS AND DEVELOPMENTS

MARKET INDICATORS

  • Table 1 Consumer Expenditure on Health Goods and Medical Services 2005-2010
  • Table 2 Life Expectancy at Birth 2005-2010

MARKET DATA

  • Table 3 Sales of Consumer Health by Category: Value 2005-2010
  • Table 4 Sales of Consumer Health by Category: % Value Growth 2005-2010
  • Table 5 Sales of Consumer Health by Region: Value 2005-2010
  • Table 6 Sales of Consumer Health by Region: % Value Growth 2005-2010
  • Table 7 Sales of Consumer Health by Rural-Urban % Value Analysis 2010
  • Table 8 Consumer Health Company Shares by Value 2006-2010
  • Table 9 Consumer Health Brand Shares by Value 2007-2010
  • Table 10 Sales of Consumer Health by Distribution Format: % Analysis 2005-2010
  • Table 11 Sales of Consumer Health by Category and Distribution Format: % Analysis 2010
  • Table 12 Forecast Sales of Consumer Health by Category: Value 2010-2015
  • Table 13 Forecast Sales of Consumer Health by Category: % Value Growth 2010-2015
  • Table 14 Forecast Sales of Consumer Health by Region: Value 2010-2015
  • Table 15 Forecast Sales of Consumer Health by Region: % Value Growth 2010-2015

APPENDIX

OTC Registration and Classification

Vitamins and Dietary Supplements’ Registration and Classification

Self-medication/self-care and Preventative Medicine

Switches

DEFINITIONS

  • Summary 1 Research Sources

Consumer Health in India - Company Profiles

Amrutanjan Health Care Ltd - Consumer Health - India

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 3 Amrutanjan Health Care Ltd: Competitive Position 2010

Amway India Enterprises - Consumer Health - India

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 6 Amway India Enterprises: Competitive Position 2010

Dabur India Ltd - Consumer Health - India

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 9 Dabur India Ltd: Competitive Position 2010

Emami Ltd - Consumer Health - India

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 12 Emami Ltd: Competitive Position 2010

Guardian Lifecare Pvt Ltd - Consumer Health - India

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

INTERNET STRATEGY

PRIVATE LABEL

COMPETITIVE POSITIONING

Herbalife International India Pvt Ltd - Consumer Health - India

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 16 Herbalife International India Pvt Ltd: Competitive Position 2010

Novartis India Ltd - Consumer Health - India

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 19 Novartis India Ltd: Competitive Position 2010

Paras Pharmaceuticals Ltd - Consumer Health - India

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 21 Paras Pharmaceuticals Ltd: Competitive Position 2010

Procter & Gamble Hygiene & Health Care Ltd - Consumer Health - India

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 24 Procter & Gamble Hygiene & Healthcare Ltd: Competitive Position 2010

Ranbaxy Laboratories Ltd - Consumer Health - India

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 27 Ranbaxy Laboratories Ltd: Competitive Position 2010

Adult Mouth Care in India - Category Analysis

HEADLINES

TRENDS

  • Sales of adult mouth careproducts in India are dominated by medicated mouthwashes and ulcer gels. Other than Smyle Mouth Ulcer Gel, which is advertised in mass media, most other brands rely on medical professionals such as dentists or general practitioners to make consumers aware of the usage and benefits of these products. Most mouthwash brands are marketed to doctors only and average consumers tend to be unfamiliar with the brands and their benefits.

SWITCHES

COMPETITIVE LANDSCAPE

  • Adult mouth care continued to be led in 2010 by Maneesh Pharmaceuticals Pvt Ltd’s Smyle Mouth Ulcer Gel, which commanded a 40% value share. Despite the presence of several other ulcer gel brands, including Zytee by Raptakos Brett & Co Ltd, Smyle Mouth Ulcer Gel was nearly synonymous with the category. Mouthwash brands – for example, Betadine Gargle, Hexidine, Piodin and Clohex – together accounted for a 27% value share in 2010.

PROSPECTS

  • Demand for ulcer treatment products is expected to continue to increase as more educated consumers seek treatment instead of just bearing with the discomfort of mouth ulcers. Growth is also expected to be driven mainly by sales of products introduced to consumers by their doctors, particularly medicated mouthwashes. Sales growth is expected to be dominated by urban sales, as urban consumers are expected to become increasingly conscious of oral health.

CATEGORY DATA

  • Table 16 Sales of Adult Mouth Care: Value 2005-2010
  • Table 17 Sales of Adult Mouth Care: % Value Growth 2005-2010
  • Table 18 Adult Mouth Care Company Shares by Value 2006-2010
  • Table 19 Adult Mouth Care Brand Shares by Value 2007-2010
  • Table 20 Forecast Sales of Adult Mouth Care: Value 2010-2015
  • Table 21 Forecast Sales of Adult Mouth Care: % Value Growth 2010-2015

Analgesics in India - Category Analysis

HEADLINES

TRENDS

  • With the absence of OTC products in categories such as child-specific analgesics and ibuprofen, and rampant UTC sales of Rx-only brands such as Combiflam, topical analgesics accounted for nearly 75% of analgesics’ total value in India at the end of the review period. In addition to their widespread availability, topical analgesics benefit from being perceived as multipurpose products which sooth tension and act as sleeping aids.

SWITCHES

COMPETITIVE LANDSCAPE

  • Emami Ltd became the leader of analgesics in 2010 by overtaking GlaxoSmithKline Consumer Healthcare Ltd with a margin of half a percentage point. Emami Ltd had an 18% value share in 2010 due to its brands Himani Fast Relief, Emami Mentho Plus and Zandu Balm. The company benefited from giving iconic brand Zandu Balm a facelift with new packaging, expanding its rural distributionand launching a low-priced small SKU (1.2g at Rs2.00) for pushing trials. GlaxoSmithKline Consumer Healthcare Ltd had a strong position in both topical and systemic analgesics with Iodex and Crocin in 2010. Third-placed player Amrutanjan Health Care Ltd held a 9% value share, deriving much of its sales from South and East India.

PROSPECTS

  • Topical analgesics are expected to continue to dominate over the forecast period. However, growth is also expected to be driven by rising demand for systemic analgesics in rural areas, as well as upgrading by urban consumers to value-added formats and formulations, such as Crocin Quik, and topical sprays and patches.

CATEGORY DATA

  • Table 22 Sales of Analgesics by Category: Value 2005-2010
  • Table 23 Sales of Analgesics by Category: % Value Growth 2005-2010
  • Table 24 Topical Analgesics/Anaesthetic by Format: % Value Breakdown 2005-2010
  • Table 25 Analgesics Company Shares by Value 2006-2010
  • Table 26 Analgesics Brand Shares by Value 2007-2010
  • Table 27 Forecast Sales of Analgesics by Category: Value 2010-2015
  • Table 28 Forecast Sales of Analgesics by Category: % Value Growth 2010-2015

Calming and Sleeping in India - Category Analysis

TRENDS

  • Sales of calming and sleeping products remained negligible in India at the end of the review period. No OTC calming and sleeping products along the lines of Valerina (Alberto-Culver) and Unisom (Pfizer) are available in the country. Some branded herbal products, such as Himalaya Pure Herbs Ashvagandha, from the Himalaya Drug Company, are available, but most such remedies are sold unpackaged and in loose form.

Cough, Cold and Allergy (Hay Fever) Remedies in India - Category Analysis

HEADLINES

TRENDS

  • Cough, cold and allergy remedies benefited from harsh weather conditions in 2010. With a prolonged rainy season and cooler-than-usual temperatures throughout India, the incidence of common flu, coughs and colds was rampant. Nearly all cough and cold products benefited from strong consumer demand in 2010as the use of such products is strongly linked to the seasonal flu that occurs during the monsoons. The outbreak of H1N1 flu in 2009 also heightened consumer awareness regarding treating flu and cold symptoms quickly instead of ignoring them.

SWITCHES

COMPETITIVE LANDSCAPE

  • Procter & Gamble Hygiene & Healthcare Ltd led category sales in 2010 with a value share of 39%. The company was able to maintain its lead due to a strong performance by its Vicks portfolio, which continued to outgrow the market as a whole in 2010. Johnson &Johnson (India) Ltd came in at number two, with a 10% value share, derived from its Benadryl and Coldarin brands.

PROSPECTS

  • Steady growth is expected over the forecast period, with erratic weather patterns and rising pollution levels contributing to an increasing incidence of seasonal flu and allergy-related conditions. Recently-launched formats such as nasal sprays and patches are expected to develop a small but expanding presence in cities, where consumers are more educated. Urban consumers are already familiar with such productsas a result of UTC purchases of brands recommended by their doctors.

CATEGORY DATA

  • Table 29 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2005-2010
  • Table 30 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2005-2010
  • Table 31 Sales of Decongestants by Category: Value 2005-2010
  • Table 32 Sales of Decongestants by Category: % Value Growth 2005-2010
  • Table 33 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Value 2006-2010
  • Table 34 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Value 2007-2010
  • Table 35 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2010-2015
  • Table 36 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2010-2015

Digestive Remedies in India - Category Analysis

HEADLINES

TRENDS

  • With hectic lifestyles the demand for more convenient, tasty and effective digestive remedies increased towards the end of the review period. As such, manufacturers sought to refresh and update their offerings by expanding their product portfolios with new formats, media campaigns, packaging and flavour variants. In 2010 Dabur India Ltd launched Pudin Hara Lemon Fizz and Abbott India Ltd launched Digene Fastmelt to challenge the dominance of Eno in powder antacids. Dabur India Ltd also sought to reinvigorate Dabur Hingoli in antiflatulents by launching an ad campaign for the product for the first time in seven years. In late 2009, Ranbaxy Laboratories Ltd launched Pepflux, an antacid in lemon mint and ginger mint flavours that contains alginic acid for the prevention of acid reflux. Novartis India Ltd conducted a soft launch for Benefiber in India, anticipating rising demand for more sophisticated products such as soluble fiber.

SWITCHES

COMPETITIVE LANDSCAPE

  • Dabur India Ltd continued to lead sales of digestive remedies in India in 2010, with a 35% value share, and was followed by Abbott India Ltd, with 15%. Dabur is predominantly positioned as a herbal/traditional player, and derives its position from its dominance in digestive enzymes, while Abbott dominates the standard medical antacids category.

PROSPECTS

  • The digestive remedies environment is expected to see robust growth in demand over the forecast period as the incidence of indigestion rises due changing lifestyles. Increasingly sophisticated products are expected to be launched to cater to consumers who are looking for more effective and convenient products. The proliferation of IT-related industries, where young professionals work long hours, is expected to lower the average age of regular consumers of indigestion and heartburn remedies.

CATEGORY DATA

  • Table 37 Sales of Digestive Remedies by Category: Value 2005-2010
  • Table 38 Sales of Digestive Remedies by Category: % Value Growth 2005-2010
  • Table 39 Digestive Remedies Company Shares by Value 2006-2010
  • Table 40 Digestive Remedies Brand Shares by Value 2007-2010
  • Table 41 Forecast Sales of Digestive Remedies by Category: Value 2010-2015
  • Table 42 Forecast Sales of Digestive Remedies by Category: % Value Growth 2010-2015

Ear Care in India - Category Analysis

HEADLINES

TRENDS

  • OTC brands such as Soliwax and Waxolve continued to rely mainly on prescriptions or suggestions by GPs to drive sales in 2010, and the category remained underdeveloped.Several RX-only brands, including those containing anti-fungal ingredients such as corticosteriods, continued to see strong UTC sales due to consumer familiarity with brands such as Candid. While the use of ear drops for dissolving wax and clearing infections in children is common in urban areas, ear hygiene and related problems are ignored by most adults unless the problem is painful/persistent enough for them to be compelled to visit a physician.

SWITCHES

COMPETITIVE LANDSCAPE

  • Nulife Pharmaceuticals Ltd, with its Soliwax brand, continued to lead in 2010, with a 48% value share. It was followed by Bell Pharma Pvt Ltd, with 38%. Wax-dissolving drops such as Bell Pharma Pvt Ltd’s Waxolve and Nulife Pharmaceuticals Ltd’s Soliwax, accounted for the bulk of the sales of ear care products. Other brands at the end of the review period included ayurvedic products such as Baidyanath Kanpi, which is positioned as both analgesic and antiseptic ear drops.

PROSPECTS

  • Ear care is predicted to see a constant value CAGR of 1% over the forecast period. Ear care is expected to remain quiet and stable, with growth being driven mainly by inflation-linked price increases rather than product innovation or consumer demand.

CATEGORY DATA

  • Table 43 Sales of Ear Care: Value 2005-2010
  • Table 44 Sales of Ear Care: % Value Growth 2005-2010
  • Table 45 Ear Care Company Shares by Value 2006-2010
  • Table 46 Ear Care Brand Shares by Value 2007-2010
  • Table 47 Forecast Sales of Ear Care: Value 2010-2015
  • Table 48 Forecast Sales of Ear Care: % Value Growth 2010-2015

Emergency Contraception in India - Category Analysis

HEADLINES

TRENDS

  • Chemists, doctors and parents raised alarmsregarding the misuse of emergency contraception by young women and teenagers in 2009. With several brands promoting emergency contraceptives with brazen TV ads depicting young couples and girls resorting to the use of the products without serious thought, some young urban adults started using the product repeatedly. Several incidents of serious side effects, including abdominal cramps and menstrual abnormalities due to frequent use ofemergency contraceptives, were reported by gynaecologists. Press reports covering the rapid sales of emergency contraceptives to the youth brought to light the issue of unprotected teenage sex, which previously remained under the radar, mainly due to taboos among older generations. With state governments and medical associations urging the central government to take action, the central government put a moratorium on all mass media ads for emergency contraceptives in late 2009. It also set up a committee to develop guidelines for the marketing of emergency contraceptives.

COMPETITIVE LANDSCAPE

  • Emergency contraception was led by Piramal Healthcare Ltd which acquired the leading brand, i-pill, from Cipla Ltd in early 2010, in a bid to bolster its small but growing portfolio of OTC products. Despite being a runaway success, i-pill was the only OTC brand in Cipla Ltd’s portfolio, and the company felt ill-suited to manage it given its clear focus on Rx-only products. While Piramal Healthcare Ltd accounted for a 41%share in 2010, second-placed player Mankind Pharma Ltd had a 29%value share with Unwanted 72.

PROSPECTS

  • Emergency contraceptives were made OTC products by the government topromote the product as a family planning tool and as a means of avoiding dangerous “back alley” abortions, which are common in India. As such, it is unlikely that the government will rescind the OTC status of emergency contraception brands. However, it is expected that companies will have to work with highly restrictive guidelines for promoting the product over the forecast period. The government is expected to mandate the inclusion of warnings regarding the misuse of the product as an “abortion pill” or as a regular contraceptive in all promotional materials.

CATEGORY DATA

  • Table 49 Sales of Emergency Contraception: Value 2008-2010
  • Table 50 Sales of Emergency Contraception: % Value Growth 2008-2010
  • Table 51 Emergency Contraception Company Shares by Value 2006-2010
  • Table 52 Emergency Contraception Brand Shares by Value 2007-2010
  • Table 53 Forecast Sales of Emergency Contraception: Value 2010-2015
  • Table 54 Forecast Sales of Emergency Contraception: % Value Growth 2010-2015

Eye Care in India - Category Analysis

HEADLINES

TRENDS

  • At the end of the review period OTC eye care brands available in India included only a couple of ayurvedic brands and a few dry eye brands such as I-Tone Eye Drops by Dey’s Medical Stores (Mfg) Ltd and Aqua Tears by Cipla Ltd. These brands had a very low profile in 2010 and did not see high sales penetration in India. As such, eye care sales remained negligible in 2010.

SWITCHES

COMPETITIVE LANDSCAPE

  • I-Tone Eye Drops by Dey’s Medical Stores (Mfg) Ltd was the most prominent eye care brand in India in 2010. However, given the lack of marketing and promotionalactivities, the brand did not have very high consumer awareness and its penetration in India was low.

PROSPECTS

  • Given the relatively high penetration of UTC sales of Refresh Tears and Tears Plus there is strong demand for dry eye products in India. However, eye care sales are not expected to take off in future unless OTC manufacturers invest in building consumer awareness regarding the usage of eye care products.

Herbal/Traditional Products in India - Category Analysis

HEADLINES

TRENDS

  • Several herbal/traditional products received a makeover in 2010, with players updating the format, flavour variants and marketing for brands such as Dabur Chawanprash, Iodex, Pudin Hara, Mediker etc. While Dabur Chyawanprash was updated with the launch of fruit-flavoured variants, Mediker anti-lice oil was rebranded as Mediker Natural Anti-lice Oil in 2010. Pudin Hara, which was previously available in pill and liquid forms, was launched in powder format to compete with Eno in antacids. Iodex launched a new variants – Iodex Headfast – to cater to rising demand for specific products in topical analgesics.

COMPETITIVE LANDSCAPE

  • Emami Ltd was the leading herbal/traditional products player in India in 2010 with a 17% value share. The company overtook Dabur India Ltd in 2009 with the acquisition of Zandu Pharmaceutical Works Ltd. Dabur India Ltd had 15% value share in 2010. While the toptwo players had a heavy emphasis on ayurvedic formulations, third-placed Procter & Gamble Hygiene & Health Care Ltd benefited from classifying multinational brand Vicks as an Ayurvedic Proprietary Medicine. Vicks variants were available in a wide range of herbal formulations and flavours in India in 2010.

PROSPECTS

  • As education levels rise, consumer awareness of the possible side effects of OTC remedies and the risk associated with self-medication through the UTC route is expected to increase. This is likely to benefit herbal/traditional products in urban areas, and in the absence of a well-defined OTC regulatory framework, manufacturers are expected to increasingly position their OTC products as ayurvedic products to tap rural growth through grocery outlet distribution.

CATEGORY DATA

  • Table 55 Sales of Herbal/Traditional Products: Value 2005-2010
  • Table 56 Sales of Herbal/Traditional Products: % Value Growth 2005-2010
  • Table 57 Herbal/Traditional Products Company Shares 2006-2010
  • Table 58 Herbal/Traditional Products Brand Shares 2007-2010
  • Table 59 Forecast Sales of Herbal/Traditional Products: Value 2010-2015
  • Table 60 Forecast Sales of Herbal/Traditional Products: % Value Growth 2010-2015

Medicated Skin Care in India - Category Analysis

HEADLINES

TRENDS

  • 2009 and 2010 witnessed product innovation and new launches which boosted growth in categories such as acne treatments, lice treatments and antipruritics. The increased availability of newerformats such as Proactiv Solution Acne Kit, Clean & Clear Active Clear Acne Clearing Gel, Mediker Natural Anti-lice Oil and Itch Guard Insect Bite Gel boosted growth in medicated skin care categories that saw single digit value growth in previous years. Moreover, the launch of small packsizes by Paras Pharmaceuticals Ltd for its medicated skin care products proved highly successful in increasing product awareness and sales penetration in small towns with fewer than 100,000 residents.

SWITCHES

COMPETITIVE LANDSCAPE

  • Emami Ltd continued to lead medicated skin care in 2010 with a value share of 38%, through its Himani Boroplus brand. GD Pharmaceuticals Pvt Ltd ranked second with 9%share and Johnson & Johnson (India) Ltd came third with 8% due to its strong position in antipruritics and medicated shampoo.

PROSPECTS

  • Competition is expected to intensify in medicated skin care over the forecast period with well established OTC brands facing pressure due to the expansion of private label products. With consumers looking to actively treat conditions such as acne, infections and rashes instead of just ignoring them as they did in the past, players are expected to find medicated skin care an attractive category to enter in coming years.

CATEGORY DATA

  • Table 61 Sales of Medicated Skin Care by Category: Value 2005-2010
  • Table 62 Sales of Medicated Skin Care by Category: % Value Growth 2005-2010
  • Table 63 Acne Treatments by Format: % Value Breakdown 2005-2010
  • Table 64 Medicated Skin Care Company Shares by Value 2006-2010
  • Table 65 Medicated Skin Care Brand Shares by Value 2007-2010
  • Table 66 Acne Treatments Brand Shares by Value 2007-2010
  • Table 67 Forecast Sales of Medicated Skin Care by Category: Value 2010-2015
  • Table 68 Forecast Sales of Medicated Skin Care by Category: % Value Growth 2010-2015

NRT Smoking Cessation Aids in India - Category Analysis

HEADLINES

TRENDS

  • Sales of NRT smoking cessation aids did not take off over the review period. However, with consumers’ health consciousness intensifying, manufacturers launched OTC NRT smoking cessation aids in India in 2010.Elder Pharmaceuticals Ltd tied up with Gelnova Laboratories (India) PvtLtd to start manufacturing NRT Lozenges in pastille format in June 2010. In a related development, regional player Louis Herbals launched Louis Herbals Anti Smoker Spray in herbal/traditional smoking cessation aids in select supermarkets and chemists in Kolkata in June 2010.While Elder Pharmaceuticals Ltd is expected to focus on the prescription route topromoteits NRT lozenges, Johnson & Johnson (India) Ltd placed great emphasis on OTC sales for Nicorette NRT Gum in India. The company launched its international best-selling brand in India in December 2010 with a large scale mass media campaign to increase awareness and create demand for the product.

SWITCHES

COMPETITIVE LANDSCAPE

  • The main NRT smoking cessation aids brand available in India in 2010 was Nulife Chewettes by Ceejay Healthcare Ltd, with Johnson & Johnson Ltd’s Nicorette being launched and quickly gaining prominence in December of that year.

PROSPECTS

  • With Johnson & Johnson (India) Ltd putting its weight behind Nicorette in early 2011, sales of NRT smoking cessation aids are expected to pick up steam over the forecast period. Other OTC and Rx NRT manufacturers, including Cipla Ltd, Louis Herbals and Elder Pharmaceuticals Ltd, are expected to benefit from Nicorette’s advertising campaign, and the category is expected to receive a hefty boost in terms of consumer awareness and demand in the early part of the forecast period.

Sports Nutrition in India - Category Analysis

HEADLINES

TRENDS

  • The bulk of sales of sports nutrition products in India are attributable to ad hoc or parallel imports from gym trainers to end consumers. Most Indian consumers purchase sports nutrition products directly from wholesalers or distributors. Very often, coaches or gym trainers act as distributors for the products, importing or purchasing them directly from manufacturers and selling them to consumers at prices lower than the specified maximum retail price (MRP).

COMPETITIVE LANDSCAPE

  • Plethico India Ltd, with Coach’s Formula, and Medinn Belle Herbal Care Pvt Ltd, with Endura Mass, were the leading players in the organised retail channels for sports nutrition in 2010.

PROSPECTS

  • With sports nutrition products being too expensive for most urban young people and average consumers generally being unaware of such products, sales through organised channels are expected to remain negligible over the forecast period. However, with awareness rising, as more people are introduced to sports nutrition products through gyms, manufacturers are expected to increase their emphasis on organised retail channels, such as pharmacies and supermarkets.

Vitamins and Dietary Supplements in India - Category Analysis

HEADLINES

TRENDS

  • Maintaining a healthy body and strong immune system was on the minds of urban Indian consumers towards the end of the review period. While the outbreak of H1N1 flu highlighted general well-being and immunity-building products in 2009, urban air pollution due to large-scale construction projects, prolonged monsoons and extra cold winters ensured that this consumer sentiment remained strong in 2010. A rising incidence of other diet-related health problems, including obesity, chronic indigestion and cardiac problems, also resulted in greater demand for vitamins and dietary supplements towards the end of the review period.

VITAMINS

DIETARY SUPPLEMENTS

COMPETITIVE LANDSCAPE

  • Amway India Enterprises continued to lead sales in 2010 with a 21% value share. Its brand Nutrilite was the leading brand in the major categories of multivitamins and protein powder, and it has a strong presence in other categories, including garlic and combination dietary supplements. In 2009 and 2010 the company witnessed rapid expansion in the number of distributors in small cities and towns, and reinforced its word-of-mouth marketing with a TV campaign highlighting its brand philosophy.

PROSPECTS

  • With consumers becoming increasingly health conscious and disposable incomes rising, vitamins and dietary supplements are expected to see strong growth over the forecast period. The factors driving growth in future will include format and flavour innovationand aggressive mass media marketing by manufacturers. The promotion of brands such as Revital and Nutrigo through mass media will contribute to increasing overall consumer awareness regarding general well-being supplements, and trickle down to benefit brands which are not active promotions and marketing, such as Becosules.

CATEGORY DATA

  • Summary 28 Dietary Supplements: Brand Ranking by Positioning 2010
  • Table 69 Sales of Vitamins and Dietary Supplements by Category: Value 2005-2010
  • Table 70 Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2005-2010
  • Table 71 Dietary Supplements by Positioning 2005-2010
  • Table 72 Vitamins and Dietary Supplements Company Shares by Value 2006-2010
  • Table 73 Vitamins and Dietary Supplements Brand Shares by Value 2007-2010
  • Table 74 Vitamins Brand Shares by Value 2007-2010
  • Table 75 Dietary Supplements Brand Shares by Value 2007-2010
  • Table 76 Forecast Sales of Vitamins and Dietary Supplements by Category: Value 2010-2015
  • Table 77 Forecast Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2010-2015

Weight Management in India - Category Analysis

HEADLINES

TRENDS

  • While rising consciousness of health and appearance in urban areas boosted consumer interest in weight management in India, products and information were still hard to find in the regular retail and media channels for the majority of consumers over the review period. Moreover, domestic manufacturers such as The Himalaya Drug Co and Goodcare Pharma Pvt Ltd, which are focussed mainly on catering to ayurvedic pharmacies and doctors, were unable to invest in educating consumers and expanding distribution presence. The ability of direct sellers to provide personalised advice and product delivery made them well-suited to satisfying consumers’ latent demand for slimming products. Direct sellers were able to capitalise on small town consumers’ yearning for extra income as well as quality healthcare and beauty products, and their rapid growth unlocked the potential in weight management products in India towards the end of the review period.

COMPETITIVE LANDSCAPE

  • Herbalife International India Pvt Ltd leads sales of weight management products thanks to its flagship brand, Shapeworks. The company commanded a 78% value share in 2010 and had a significant lead over the second-placed player, Amway India Enterprises, which held an 11% share with its Positrim brand, aided by its growing presence in meal replacement slimming products. The third-largest player with a 6%share, The Himalaya Drug Co, saw its share shrink sharply towards the end of the review period as the growth of direct sellers’ brands was many times stronger than the growth of its Ayurslim brand.

PROSPECTS

  • While most of the action in weight management took place in the direct selling channel over the review period, activity in the retail channel is expected to intensify over the forecast period as more domestic players try to grab a slice of sales, and as weight consciousness spreads from the highly affluent to middle class consumers in the major cities. However, consumers are expected to continue to look towards direct sellers such as Amway and Herbalife for weight management products, as the latter are able to provide consumers with the products as well as information and advisory services, such as customised diet and lifestyle plans for losing weight.

CATEGORY DATA

  • Table 78 Sales of Weight Management: Value 2005-2010
  • Table 79 Sales of Weight Management: % Value Growth 2005-2010
  • Table 80 Weight Management Company Shares 2006-2010
  • Table 81 Weight Management Brand Shares 2007-2010
  • Table 82 Forecast Sales of Weight Management: Value 2010-2015
  • Table 83 Forecast Sales of Weight Management: % Value Growth 2010-2015

Wound Care in India - Category Analysis

HEADLINES

TRENDS

  • Wound care was not very dynamic in terms of new product launches and marketing campaigns, with growth driven largely by rising purchasing power. This has resulted in consumers purchasing branded products for the treatment of wounds.

COMPETITIVE LANDSCAPE

  • Johnson & Johnson (India) Ltd continued to dominate wound treatments in 2010, with a 71% value share. Its brands Band-Aid and Dynacrepe have very high brand recall, and are widely available across both grocery and non-grocery channels in India. Johnson & Johnson (India) Ltd is followed by Beiersdorf India Ltd, with a 19% value share, through the brands Hansaplast and Leukocrepe.

PROSPECTS

  • As consumer sophistication increases, product innovation is expected to gain prominence over the forecast period, e.g. premium products that are common in developed markets, including sensitive skin and cushioned sticking plasters, are expected to be launched in India.

CATEGORY DATA

  • Table 84 Sales of Wound Care by Category: Value 2005-2010
  • Table 85 Sales of Wound Care by Category: % Value Growth 2005-2010
  • Table 86 Wound Care Company Shares by Value 2006-2010
  • Table 87 Wound Care Brand Shares by Value 2007-2010
  • Table 88 Forecast Sales of Wound Care by Category: Value 2010-2015
  • Table 89 Forecast Sales of Wound Care by Category: % Value Growth 2010-2015

Segmentation

Segmentation

This market research report includes the following:

  • Consumer Health
    • OTC
      • Adult Mouth Care
      • Analgesics
        • Systemic Analgesics
          • Adult Analgesics
            • Acetaminophen
            • Aspirin
            • Combination Products - Analgesics
            • Diclofenac
            • Dipyrone
            • Ibuprofen
            • Ketoprofen
            • Naproxen
          • Child-Specific Analgesics
            • Child-Specific Acetaminophen
            • Child-Specific Aspirin
            • Child-Specific Combination Products - Analgesics
            • Child-Specific Diclofenac
            • Child-Specific Dipyrone
            • Child-Specific Ibuprofen
            • Child-Specific Ketoprofen
            • Child-Specific Naproxen
        • Topical Analgesics/Anaesthetic
      • Calming and Sleeping
      • Cough, Cold and Allergy (Hay Fever) Remedies
        • Antihistamines/Allergy Remedies (Systemic)
        • Child-Specific Cough, Cold and Allergy Remedies
          • Child-Specific Allergy Remedies
          • Child-Specific Cough/Cold Remedies
        • Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies
        • Cough Remedies
        • Decongestants
          • Nasal Sprays
          • Oral Decongestants
          • Inhalant Decongestants
          • Decongestant Rubs
          • Nasal Decongestant Drops
          • Nasal Decongestant Plasters
        • Medicated Confectionery
        • Pharyngeal Preparations
      • Digestive Remedies
        • Child-Specific Digestive Remedies
          • Child-Specific Diarrhoeal Remedies
          • Child-Specific Indigestion and Heartburn Remedies
          • Child-Specific Laxatives
          • Child-Specific Motion Sickness Remedies
        • Diarrhoeal Remedies
        • IBS Treatments
        • Indigestion and Heartburn Remedies
          • Antacids
          • Antiflatulents
          • Digestive Enzymes
          • H2 Blockers
          • Proton Pump Inhibitors
        • Laxatives
        • Motion Sickness Remedies
      • Ear Care
      • Emergency Contraception
      • Eye Care
        • Allergy Eye Care
        • Standard Eye Care
      • Medicated Skin Care
        • Acne Treatments
        • Medicated Shampoos
        • Topical Antifungals
        • Vaginal Antifungals
        • Hair Loss Treatments
        • Nappy (Diaper) Rash Treatments
        • Antiparasitics/Lice (Head and Body) Treatments
        • Antipruritics
        • Child-Specific Medicated Skin Care
        • Cold Sore Treatments
        • Haemorrhoid Treatments
        • Topical Allergy Remedies/Antihistamines
        • Topical Germicidals/Antiseptics
      • NRT Smoking Cessation Aids
        • NRT Gum
        • NRT Inhalators
        • NRT Lozenges
        • NRT Patches
        • Other NRT
      • OTC Triptans
      • Wound Care
        • First Aid Kits
        • Sticking Plasters/Adhesive Bandages
        • Gauze, Tape and Other Wound Care
    • Sports Nutrition
    • Vitamins and Dietary Supplements
      • Child-Specific Vitamins and Dietary Supplements
      • Dietary Supplements
        • Combination Dietary Supplements
        • Herbal/Traditional Dietary Supplements
          • Combination Herbal/Traditional Dietary Supplements
          • Echinacea
          • Evening Primrose Oil
          • Garlic
          • Ginkgo Biloba
          • Ginseng
          • St John's Wort
          • Other Herbal/Traditional Dietary Supplements
            • Ayurvedic Single Herbs
            • Chyawanprash
            • Isoflavones
        • Non-Herbal Dietary Supplements
          • Calcium Supplements
          • Co-Enzyme Q10
          • Combination Non-Herbal Dietary Supplements
          • Eye Health Supplements
          • Fish Oils
            • Cod Liver Oil
            • Other Fish Oils
          • Glucosamine
          • Mineral Supplements
          • Omega-3-6-9 (Fish and Non-Fish)
          • Probiotic Supplements
          • Protein Powder
          • Royal Jelly
          • Sam-E
          • Other Non-Herbal Dietary Supplements
            • Glucose Powder
      • Tonics and Bottled Nutritive Drinks
      • Vitamins
        • Multivitamins
        • Single Vitamins
          • Vitamin A
          • Vitamin B
          • Vitamin C
          • Vitamin D
          • Vitamin E
          • Other Single Vitamins
    • Weight Management
      • Meal Replacement Slimming
      • OTC Obesity
      • Slimming Teas
      • Weight Loss Supplements
      • Other Slimming Products
    • Herbal/Traditional Products
      • Herbal/Traditional Analgesics
      • Herbal/Traditional Calming and Sleeping Products
      • Herbal/Traditional Cough, Cold and Allergy (Hay Fever) Remedies
      • Herbal/Traditional Digestive Remedies
      • Herbal/Traditional Medicated Skin Care
      • Herbal/Traditional Medicinal Teas
      • Herbal/Traditional Smoking Cessation Aids
      • Herbal/Traditional Child-Specific Dietary Supplements
      • Herbal/Traditional Dietary Supplements
      • Herbal/Traditional Tonics and Bottled Nutritive Drinks
    • Allergy Care
      • Allergy Eye Care
      • Antihistamines/Allergy Remedies (Systemic)
      • Child-Specific Allergy Remedies
      • Topical Allergy Remedies/Antihistamines
    • Child-Specific Consumer Health
      • Child-Specific Analgesics
        • Child-Specific Acetaminophen
        • Child-Specific Aspirin
        • Child-Specific Combination Products - Analgesics
        • Child-Specific Diclofenac
        • Child-Specific Dipyrone
        • Child-Specific Ibuprofen
        • Child-Specific Ketoprofen
        • Child-Specific Naproxen
      • Child-Specific Cough, Cold and Allergy Remedies
        • Child-Specific Allergy Remedies
        • Child-Specific Cough/Cold Remedies
      • Child-Specific Digestive Remedies
        • Child-Specific Diarrhoeal Remedies
        • Child-Specific Indigestion and Heartburn Remedies
        • Child-Specific Laxatives
        • Child-Specific Motion Sickness Remedies
      • Child-Specific Medicated Skin Care
      • Nappy (Diaper) Rash Treatments
      • Child-Specific Vitamins and Dietary Supplements

Statistics Included

Statistics Included

For each category and subcategory you will receive the following data in Excel format:

From Passport

  • Market sizes
  • Company shares
  • Brand shares
  • Distribution
  • Analysis by format
  • Analysis by positioning
  • Herbal/traditional vs standard
  • Pricing
  • Urban vs rural

Market size details:

  • Retail volume
  • Retail volume % growth
  • Retail volume per capita
  • Retail value retail selling price % growth
  • Retail value retail selling price local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price real (constant 2008) prices % growth
  • Retail value retail selling price real (constant 2008) prices local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price real (constant 2008) prices per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price % growth
  • Retail value manufacturer selling price local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price real (constant 2008) prices % growth
  • Retail value manufacturer selling price real (constant 2008) prices local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price real (constant 2008) prices per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price nominal (current) prices % growth
  • Retail value retail selling price nominal (current) prices local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price nominal (current) prices per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price nominal (current) prices % growth
  • Retail value manufacturer selling price nominal (current) prices local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price nominal (current) prices per capita local currency, USD, EUR, GBP, CHF, JPY

Methodology

Methodology

Global insight and local knowledge

With 40 years’ experience of developed and emerging markets, Euromonitor International’s research method is built on a unique combination of specialist industry knowledge and in-country research expertise.

This approach is what enables us to achieve our goal of building a market consensus view of size, shape and trends across the full distribution universe of each category. We factor in whichever channels are relevant, from large-scale grocery to direct sellers, from discount stores to local mom-and-pop outlets.

Industry specialists

Each industry we cover is managed by an Industry Manager and team of Industry Analysts who research and report on their specialist categories all year round.

Our collaborative approach to research means that these industry teams are in constant dialogue with industry players and opinion formers. The planning of our research programmes reflects latest market trends and industry events. In completing each update project, this provides invaluable input to the testing, review and finalisation of our data.

The specialist in-house teams bring together findings from all stages of the annual research process. They work closely with in-country analysts, assess and challenge data and exercise final editorial control over the publication of new data and analysis.

Country and regional analysts

Our in-country analyst network is managed by country and regional analysts in our offices around the world. Working closely with each in-country team, the regional research management team ensures that all country researchers are well schooled in best practices, from the information collected in store checks, to the dialogue we build in trade surveys. Our country analysts ensure that national reports explain the data trends and provide clear insights into the local market’s dynamics.

In-country research network

To deliver fresh insights every year in countries all around the world, we believe the strongest approach is to use analysts on the ground. They bring fluency in local language, physical proximity to the best sources, an ability to engage directly with local industry contacts, and an awareness of how the products and services we study are advertised, sold and consumed. These are essential parts of our ability to report incisively on these markets.

Research Methodology

Our research methods

Each Euromonitor International industry report is based on a core set of research techniques:

Desk research

With industry events, corporate activity, trends and new product introductions tracked year round by our industry team, desk research provides a starting point for the in-country research programme. Our in-country researchers will access the following sources:

  • National statistics offices governmental and official sources
  • National and international trade press
  • National and international trade associations
  • Industry study groups and other semi-official sources
  • Company financials and annual reports
  • Broker reports
  • Online databases
  • The financial, business and mainstream press

Accessing sources is only the first step. The ability to interpret and reconcile often conflicting information across multiple sources is a key aspect of the added value we provide.

Store checks

Store checks are an integral part of our methods for product industries. Carried out on the ground across a relevant mix of channels, the information gained provides first-hand insights into the products we are researching, specifically:

  • Place: We track products in all relevant channels, selective and mass, store and non-store
  • Product: What are innovations in products, pack sizes and formats?
  • Price: What are brand price variations across channels, how do private label’s prices compare to those of branded goods?
  • Promotion: What are marketing and merchandising trends, offers, discounts and tie-ins?

Findings are cross-referenced with brand share data analysis. The results, combined with the findings of desk research, provide a strong basis for identifying key areas of questioning to take forward into our trade survey.

Trade survey

Interaction with global players at corporate HQ and regional levels is complemented by unique local data and insights from our in-country trade surveys around the world. Through the high profile of the Euromonitor International brand, we are able to talk directly to a wide range of sources and therefore inform our analysis with the knowledge and opinions of the leading operators in the market.

Trade surveys allow us to:

  • Fill gaps in available published data per company
  • Generate a consensus view of the size, structure and strategic direction of the category
  • Access year-in-progress data where published sources are out of date
  • Evaluate the experts’ views on current trends and market developments

In building our composite industry view, we engage with a variety of personnel in key players at all points of the supply chain: materials suppliers, manufacturers, distributors, retailers and service operators. We also interview desk research sources: industry associations; study groups; and third party observers from the trade and financial press.

Our objective is to engage in conversation with trade sources in which we exchange ideas and views on the industry, sharing our work-in-progress findings on supply/demand dynamics and potential. This dialogue enhances both parties’ understanding of the local market. The scope and reach of our trade survey also serves to eliminate bias (intentional and unintentional) from any single source.

Company analysis

At a global level, our company research combines our mix of industry interaction and use of secondary sources such as annual accounts, broker reports, financial press and databases. From a data perspective, the aim is to build “top-down” estimates of major players’ total global and regional sales.

At a country level, in line with local reporting requirements, we access annual accounts, national-specific company databases and local company websites. These are all invaluable sources as we build a view of each domestic player’s size and position within very specific categories of the industry.

Forecasts

Data projections and future performance analysis are key elements of Euromonitor International’s market intelligence. Working with historic trends of 15 years or more, a key aspect of our trade survey is to engage industry insider views of the next five years. Will volumes maintain their historic trend? Will price increases or falls of recent years continue, accelerate or slow down? Will increasing demand for one product cannibalise sales of another?

Forecasts represent many of the essential conclusions we have reached about the current state of the market, how it works and how it behaves under different macro and micro conditions. Our written analysis will state the assumptions and the trade opinion behind whether our predictions are optimistic or pessimistic, so that clients can use our statistical forecasts with confidence.

Data validation

All data is subjected to an exhaustive review process, at country, regional and global levels.

The interpretation and review of sources and data inputs forms a central part of the collaboration between industry teams and country researchers. Numbers are delivered to regional and global offices with an audit trail of sources and calculations to allow for a thorough evaluation of data sense and integrity.

Upon completion of the country review phase, data is then reviewed on a comparative basis at regional and then at a global level. Comparative checks are carried out on per capita consumption and spending levels, growth rates, patterns of category and subcategory breakdowns and distribution of sales by channel. Top-down estimates are reviewed against bottom-up regional and global market and company sales totals.

Where marked differences are seen between proximate country markets or ones at similar developmental levels, supplementary research is conducted in the relevant countries to confirm and/or amend those findings. This process ensures international comparability across the database, that consistent category and subcategory definitions have been used and that all data has been correctly tested. We make sure that possible discrepancies between different published sources have been reconciled and that our interpretation of opinion and expectation from each country’s trade sources has been applied to form a coherent international pattern.

Market analysis

Another integral part of all our research programmes is that all Euromonitor International data is accompanied by clear written analysis. From a research perspective, this explains and substantiates data findings. From a client perspective, this offers unique insights into local consumption trends, routes to market, brand preferences, channel dynamics and future trends.

Our country level analysis also provides invaluable input into the ability of our central industry specialist teams to marry local insights with strategic conclusions on the direction of the market regionally and globally.

my pages

Want to find out more about this report?

RELATED

Country Report

Consumer Lifestyle

Future Demographic

Country Report